Objective To evaluate the clinical efficacy of Guanxinning Tablets(composed of Salviae Miltiorrhizae Radix et Rhizoma and Chuangxiong Rhizoma)in patients with acute myocardial infarction(AMI)after percutaneous coronary intervention(PCI)presenting with qi stagnation and blood stasis syndrome.Methods Eighty AMI patients who underwent PCI and were diagnosed with qi stagnation and blood stasis syndrome were enrolled from Guangdong Second Traditional Chinese Medicine Hospital between January 2024 and December 2024.Patients were randomly divided into a control group(n=40)and an observation group(n=40)using a random number table.The control group received standard post-PCI treatment(Aspirin 0.1 g qd+Clopidogrel 75 mg qd),while the observation group received additional Guanxinning Tablets for 8 weeks.Serum myocardial injury markers[troponin I(TnI),N-terminal pro-B-type natriuretic peptide(NT-proBNP)],novel inflammatory indices[systemic immune-inflammation index(SII),systemic inflammation response index(SIRI)],and Seattle Angina Questionnaire(SAQ)scores were assessed before and after treatment.Clinical efficacy and safety were evaluated.Results(1)Efficacy:After 8 weeks,the total effective rate was 97.50％(39/40)in the observation group versus 92.50％(37/40)in the control group,showing a non-significant trend favoring the observation group(P＞0.05,by chi-square test).(2)Myocardial injury markers:Both groups exhibited significant improvements in TnI and NT-proBNP levels(P＜0.05),with greater improvements in the observation group(P＜0.05).(3)Inflammatory indices:SII and SIRI levels were significantly improved in both groups(P＜0.05),with superior reductions in the observation group(P＜0.01).(4)Quality of life:SAQ scores in the dimensions of physical limitation,angina stability,angina frequency,treatment satisfaction,and disease perception were improved in both groups(P＜0.05),and the observation group showed significantly better outcomes(P＜0.05 or P＜0.01).(5)Safety:No severe cardiovascular adverse events or allergic reactions occurred in either group.Mild adverse events(e.g.,dizziness,gastrointestinal discomfort)occurred in 5.00％(2/40)of both groups(P＞0.05).Conclusion Guanxinning Tablets combined with conventional post-PCI therapy significantly improve clinical symptoms,cardiac function,inflammatory response,and quality of life in AMI patients with qi stagnation and blood stasis syndrome,with excellent safety and tolerability.

PURPOSE: The purpose of this study is to investigate the impact of transitional care by a nurse-led multidisciplinary team (MDT) on clinical outcomes and quality of life of patients with ankylosing spondylitis. METHODS: A randomized control study design was used. Subjects were allocated randomly to an experimental group and a control group. The experimental group received intensive transitional care by a nurse-led MDT, whereas the control group received routine nursing care. Disease activity, spinal mobility, comprehensive function, health service utilization, and quality of life were assessed at the baseline and at six months with the Bath Ankylosing Spondylitis Metrology Index, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI), a health service utilization questionnaire and version 2 of the Short Form-36 health survey. RESULTS: Compared with the baseline, the BASDAI, BASFI, emergency visits, hospitalizations, hospitalization days, and bodily pain, vitality, mental health, total score, and average score of version 2 of the Short Form-36 health survey were improved in the experimental group (p < .05), whereas only bodily pain, vitality, and role-emotional were improved in the control group p < .05). At six months, the experimental group exhibited significantly more improvement on the BASDAI, BASFI, hospitalizations, all domains except Role-physical as well as total score and average score p < .05) compared with the control group. CONCLUSION: A MDT-based nurse-led transitional care improves clinical outcomes and quality of life of patients with ankylosing spondylitis. Future research should be carried out on modes of follow-up and family support.
Baths ; Emergencies ; Follow-Up Studies ; Health Services ; Health Surveys ; Hospitalization ; Humans ; Mental Health ; Nursing Care ; Patient Care Team ; Quality of Life ; Spondylitis, Ankylosing ; Transitional Care